Stay updated on Milademetan Safety in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedPublications section updated to include a Phase 1 milademetan dose-escalation study citation and a note that publications are automatically filled from PubMed. PubMed-derived entries may not all be about this study.SummaryDifference0.2%

- Check15 days agoChange DetectedThe revision label on the page updated from v3.6.4 to v3.6.5, indicating a maintenance release. No study information or page functionality appears to be affected.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4, indicating a new page build was deployed.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This is an administrative revision label update without substantive content changes.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows Revision: v3.6.2 in place of the previous v3.6.0, signaling a backend/UI update rather than changes to the study details.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page adds user guidance sections and a reworded Intervention/Treatment heading, and displays the recruitment status 'No longer looking for participants' while updating the revision from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.